Immunoglobulin D-Associated AL Amyloidosis: Clinical Features and Outcomes
Clinical Lymphoma Myeloma and Leukemia · 2026-10 · 26 (10) · 706-710
DOI: 10.1016/j.clml.2026.07.013 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-10. Verfasst von Sarika D Gurnani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
- Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA. Electronic address: Vaishali.Sanchorawala@bmc.org.
Zitieren
APA
Gurnani, S. D., Staron, A., Mendelson, L. M., Burke, N. J., & Sanchorawala, V. (2026). Immunoglobulin D-Associated AL Amyloidosis: Clinical Features and Outcomes. Clinical Lymphoma Myeloma and Leukemia, 26(10), 706-710. https://doi.org/10.1016/j.clml.2026.07.013
Vancouver
Gurnani SD, Staron A, Mendelson LM, Burke NJ, Sanchorawala V. Immunoglobulin D-Associated AL Amyloidosis: Clinical Features and Outcomes. Clinical Lymphoma Myeloma and Leukemia. 2026;26(10):706-710. doi:10.1016/j.clml.2026.07.013
BibTeX
@article{Gurnani2026,
author = {Gurnani, Sarika D and Staron, Andrew and Mendelson, Lisa M and Burke, Natasha J and Sanchorawala, Vaishali},
title = {Immunoglobulin D-Associated AL Amyloidosis: Clinical Features and Outcomes},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {10},
pages = {706--710},
doi = {10.1016/j.clml.2026.07.013}
}
EUVIMED